Form 4 for HCA HCA Healthcare
Accepted 2024-07-29 00:00:00 ET · period of report 2024-07-25 · accession 0000950170-24-087383 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-29 | 2024-07-25 | HCA | Wyatt Christopher F. | SVP, Ctrl | M - OptEx | $101.16 | +9,300 | 49.7K | +23% | +$940.8K |
| D | 2024-07-29 | 2024-07-25 | HCA | Wyatt Christopher F. | SVP, Ctrl | F - Tax | $352.79 | -5,278 | 44.4K | -11% | -$1.86M |
| D | 2024-07-29 | 2024-07-29 | HCA | Wyatt Christopher F. | SVP, Ctrl | S - Sale+OE | $360.20 | -4,000 | 40.4K | -9% | -$1.44M |
| D | 2024-07-29 | 2024-07-25 | HCA | Wyatt Christopher F. | SVP, Ctrl | M - OptEx | $0.00 | -9,300 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-25 | M | A | 9,300 | $101.16 | 49,727 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-25 | F | D | 5,278 | $352.79 | 44,449 | D | — | — | |
| 3 | Common | Common Stock | 2024-07-29 | S | D | 4,000 | $360.20 | 40,449 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.05 to $360.205, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Derivative | Stock Appreciation Right | 2024-07-25 | M | D | 9,300 | $0.00 | 0 | D | $101.16 · — to 2028-01-31 | 9,300 Common Stock | (F2) The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. |